Business Context and Reporting Period
This Form 6-K filing by OrangeKloud Technology Inc. (ORKT) is dated February 2, 2026. The report addresses a critical corporate governance issue regarding the company's listing status on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notice regarding listing compliance rather than a financial performance report.
Material Changes and Events
- Nasdaq Delisting Notice: On January 29, 2026, the Company received a Staff Delisting Determination from Nasdaq due to non-compliance with Listing Rule 5550(a)(2) (Minimum Bid Price Rule).
- Compliance Deficiency: The Company's stock price failed to maintain the required minimum bid price of $1.00 per share for 30 consecutive business days.
- Grace Period Ineligibility: The Company is not eligible for a 180-day grace period to regain compliance because it previously cured a similar deficiency via a reverse stock split within the last twelve months.
Outlook, Management Commentary, and Risks
- Appeal Process: Management intends to appeal the determination by requesting an oral hearing before the Nasdaq Hearings Panel. This request will stay the delisting process pending the Panel's decision.
- Trading Status: Securities will continue to trade normally on the Nasdaq Capital Market under the symbol "ORKT" during the appeal process.
- Compliance Plan: The Company will submit a written plan of compliance to the Hearings Panel and request an exception to listing standards for a limited time.
- Risks and Uncertainties: There is no assurance that the Panel will approve the compliance plan or grant the requested exception. Failure to regain compliance could result in delisting.
Investor Verification Checklist
- Verify the current stock price of ORKT to assess the severity of the bid price deficiency.
- Monitor the status of the appeal and the scheduled date for the oral hearing before the Nasdaq Hearings Panel.
- Review the Company's submitted written plan of compliance once publicly disclosed.
- Check for any subsequent announcements regarding the Panel's decision on the delisting appeal.